Walgreens, American Society of Transplantation (AST) to work over improving medication adherence for organ transplant recipients

DEERFIELD, Ill. and MOUNT LAUREL, N.J., 2017-Apr-26 — /EPR Retail News/ — Walgreens and the American Society of Transplantation (AST) today (April 24, 2017 ) announced a collaboration focused on establishing future initiatives to help improve medication adherence for organ transplant recipients. The topic of adherence and taking medications as prescribed is especially critical in transplantation, as recipients must take lifelong immunosuppressive medications to prevent possible organ rejection.

The collaboration will officially kickoff later this week with the “Tackling Medication Non-Adherence in Organ Transplantation” symposium hosted by AST and sponsored by Walgreens Specialty Pharmacy.  The meeting will take place over the two-day period (April 28 and 29) prior to the start of the American Transplant Congress (ATC) in Chicago, the premier meeting for transplant professionals which begins on April 29 in the evening.

“The symposium will bring together renowned experts from the transplant pharmacy community to identify ongoing barriers to medication adherence in organ transplantation, and to discuss how we can collectively develop and design innovative, targeted interventions to help improve adherence among transplant patients,” said Angela Maldonado, incoming Chair of the AST Transplant Pharmacy Community of Practice (COP).

At the conclusion of the symposium, as AST and Walgreens Specialty Pharmacy focus on the next steps of the collaboration, participants will become part of a new “Adherence Working Group” of the Transplant Pharmacy COP and will seek opportunities to execute these interventions.

For AST, the collaboration with Walgreens is aligned with Power2Save (www.power2save.org), AST’s public-facing initiative that takes a multi-dimensional approach to making the gift of life last a lifetime. Non-adherence is a threat to optimal outcomes after transplantation, significantly increasing the risk of organ rejection and contrary to the goal of “one transplant for life.”

“In solid organ transplantation, adherence with immunosuppressive medications is a critical issue,” said AST President Anil Chandraker, M.D. “The outcomes of non-adherence can be quite devastating, many times resulting in rejection, graft loss and even mortality. By working with Walgreens, we have the potential to effectively address this issue, with the potential for long-term collaboration on targeted interventions.”

Meen Kang, Walgreens senior director of transplant product management, said, “We look forward to working closely with AST, as our organizations share a commitment to helping transplant patients get back on the road to recovery. Our local Walgreens specialty pharmacy locations across the country work with providers and their patients during and after transplant, providing services designed to make it easy for patients to follow their transplant treatment, with a team dedicated to their individual care.”
At the symposium as well as at ATC, Walgreens will be presenting its recent study on medication adherence for transplant recipients whose immunosuppressives were covered by Medicare Part B over a one year period versus those whose coverage changed during that same period.

About AST
Founded in 1982, the American Society of Transplantation (www.myAST.org) is an organization of more than 3,500 professionals dedicated to advancing the field of transplantation and improving patient care by promoting research, education, advocacy, and organ donation. The society is the largest organization of transplant professionals in North America and is recognized as the premier society for transplantation. AST members are sought out as transplant experts and advocates. Other transplant organizations, policy makers, regulatory agencies, payors, academic institutions, and the general public look to the AST for guidance, research, and resources related to transplantation.

About Walgreens
Walgreens (www.walgreens.com), one of the nation’s largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led, health and wellbeing enterprise. More than 10 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,175 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands, along with its omnichannel business, Walgreens.com. Approximately 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services.

Contacts:

Walgreens
Scott Goldberg
847-315-7649
scott.goldberg@walgreens.com
http://news.walgreens.com
@WalgreensNews
facebook.com/Walgreens

American Society of Transplantation (AST)
Shauna O’Brien
609-226-3924
sobrien@myast.org

Source: Walgreens

Medication naloxone now available without prescription at CVS Pharmacy locations in Idaho

WOONSOCKET, R.I., 2016-Aug-16 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today that the opioid overdose-reversal medication naloxone is now available without a prescription at CVS Pharmacy locations in Idaho. Under prescriptive authority allowed by the state, CVS Pharmacists will expand access to the medication.

“Naloxone is a safe and effective antidote to opioid overdoses and we can help save lives by increasing access to this medication in our Idaho pharmacies by the use of prescriptive authority for patients without a prescription,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “We are dedicated to helping the communities we serve address and prevent drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery.”

In addition to Idaho, CVS Pharmacy locations in 30 other states can dispense naloxone to patients without an individual prescription.

“CVS Health has been a leader in helping communities prevent prescription drug abuse and we applaud their work to increase access to this life-saving drug for patients without a prescription at CVS Pharmacy locations in Idaho,” said Marcia Lee Taylor, President and CEO, Partnership for Drug-Free Kids. “Increasing access to naloxone is a critical public health priority that allows patients and their families to prevent opioid fatalities and recognize when people need help working towards recovery from the disease of addiction.”

CVS Health has also launched digital resources on www.cvs.com/content/prescription-drug-abuse giving patients and families a single destination to learn more about drug abuse prevention. These new resources build on CVS Health’s longstanding commitment to helping communities address and prevent drug abuse. In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. More than 100,000 students have already taken part in the program. High school teachers and administrators in Idahocan learn more about bringing Pharmacists Teach to their school here.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments, providing a safe and environmentally friendly way to dispose of unwanted medication. Law enforcement officials across Idaho can apply to receive a drug collection unit here.

About CVS Health
CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

###

Medication naloxone now available without prescription at CVS Pharmacy locations in Idaho
Medication naloxone now available without prescription at CVS Pharmacy locations in Idaho

 

SOURCE: CVS Health